Royalty Pharma plc — Company profile
Healthcare · Biotechnology · United States
Last price 67.18 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 38.63B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Details
| Name | Royalty Pharma plc |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 100 |
| Founded | 1996 |
| Ipo Date | 2020-06-16 |
| Ceo | Pablo Legorreta |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 28.00 |
| Isin | GB00BMVP7Y09 |
| Cusip | G7709Q104 |
| Cik | 0001802768 |
| Sic | 2834 |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Pablo Legorreta | Founder, Chairman of the Board and Chief Executive Officer |
| Terrance P. Coyne | Executive Vice President and Chief Financial Officer |
| Christopher Hite | Chairman of Partnering and Investments |
| Dr. Marshall Jonathan Urist M.D., Ph.D. | Head of Research and Investments |
| Greg Butz | Executive Vice President of Partnering and Investments |
| Eric Cornelius Schneider | Senior Vice President and Chief Technology Officer |
| Dr. James Folmar Reddoch Ph.D. | Executive Vice President of Investments and Chief Scientific Officer |
| George Grofik C.F.A., CPA | Senior Vice President and Head of Investor Relations and Communications |
| Arthur Richard McGivern J.D. | Executive Vice President of Investment and Chief Legal Officer |
| Molly Sawaya | Executive Vice President and Head of Human Capital |
Contact
| Address | 110 East 59th Street, New York, New York 10022, United States |
| Phone | 212 883 0200 |
| Website | https://www.royaltypharma.com |